<?xml version="1.0" encoding="UTF-8"?>
<p>CBDA exerted anti-inflammatory activity in receptor level by stimulating vanilloid 1 and ankyrin 1 transient receptor potential (TRP) channels (TRPV1 and TRPA1, respectively) or by antagonizing the Transient Receptor Potential Cation Channel Subfamily M Member 8 (TRPM8) with IC
 <sub>50</sub> value ranging 0.9–1.6 µM [
 <xref rid="B67-ijms-21-09049" ref-type="bibr">67</xref>]. COX2 is mainly involved in an inflammatory response. CBDA acts as a selective inhibitor of COX2 with an IC
 <sub>50</sub> value of approximately 2 µM [
 <xref rid="B68-ijms-21-09049" ref-type="bibr">68</xref>]. Intraperitoneal administration of rodent with CBDA (10 μg/kg) 60 min prior to treatment with carrageenan produced anti-inflammatory effects in a dose-dependent manner but orally did not [
 <xref rid="B69-ijms-21-09049" ref-type="bibr">69</xref>].
</p>
